Evans P C

Top coauthors of Evans P C

Harding J E (12 papers)

Gluckman P D (7 papers)

Wreghitt T G (6 papers)

Alexander G J (6 papers)

Paxton J W (6 papers)

List of Evans P C publications

2016

Halliday I, Lishchuk S V, Spencer T J, Pontrelli G, Evans P C 2016. "Local membrane length conservation in two-dimensional vesicle simulation using a multicomponent lattice Boltzmann equation method." Physical review. E 94 (2-1) doi:10.1103/PhysRevE.94.023306

2011

Halliday I, Atherton M, Care C M, Collins M W, Evans D, et al. 2011. "Multi-scale interaction of particulate flow and the artery wall." Medical engineering & physics 33 (7) doi:10.1016/j.medengphy.2010.09.007

2010

Hummel J, Evans P C, Lee H 2010. "Medication reconciliation in the emergency department: opportunities for workflow redesign." Quality & safety in health care 19 (6) doi:10.1136/qshc.2009.035121

2007

Adcock I, Evans P C 2007. "Resolution of Inflammatory Responses: a brief introduction." Biochemical Society transactions 35 (Pt 2) doi:10.1042/BST0350261

2005

Goodman R S, Ewing J, Evans P C, Craig J, Poulton K, et al. 2005. "Donor CD31 genotype and its association with acute graft-versus-host disease in HLA identical sibling stem cell transplantation." Bone marrow transplantation 36 (2) doi:10.1038/sj.bmt.1705013

2001

Evans P C, Taylor E R, Coadwell J, Heyninck K, Beyaert R, Kilshaw P J 2001. "Isolation and characterization of two novel A20-like proteins." The Biochemical journal 357 (Pt 3) doi:
Evans P C, Smith S, Hirschfield G, Rigopoulou E, Wreghitt T G, et al. 2001. "Recipient HLA-DR3, tumour necrosis factor-alpha promoter allele-2 (tumour necrosis factor-2) and cytomegalovirus infection are interrelated risk factors for chronic rejection of liver grafts." Journal of hepatology 34 (5) doi:
Evans P C, Taylor E R, Kilshaw P J 2001. "Signaling through CD31 protects endothelial cells from apoptosis." Transplantation 71 (3) doi:

2000

Evans P C, Kilshaw P J 2000. "Interleukin-13 protects endothelial cells from apoptosis and activation: association with the protective genes A20 and A1." Transplantation 70 (6) doi:
Lambert N C, Evans P C, Hashizumi T L, Maloney S, Gooley T, et al. 2000. "Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity." Journal of immunology (Baltimore, Md. : 1950) 164 (11) doi:
Jensen E C, van Zijl P, Evans P C, Harding J E 2000. "Effect of IGF-I on serine metabolism in fetal sheep." The Journal of endocrinology 165 (2) doi:
Evans P C, Soin A, Wreghitt T G, Taylor C J, Wight D G, Alexander G J 2000. "An association between cytomegalovirus infection and chronic rejection after liver transplantation." Transplantation 69 (1) doi:

1999

Evans P C, Coleman N, Wreghitt T G, Wight D G, Alexander G J 1999. "Cytomegalovirus infection of bile duct epithelial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of liver grafts." Journal of hepatology 31 (5) doi:
Evans P C, Gray J J, Wreghitt T G, Marcus R E, Alexander G J 1999. "Comparison of three PCR techniques for detecting cytomegalovirus (CMV) DNA in serum, detection of early antigen fluorescent foci and culture for the diagnosis of CMV infection." Journal of medical microbiology 48 (11) doi:
Nasu K, Whyte A, Green S J, Evans P C, Kilshaw P J 1999. "Alpha-galactosyl-mediated activation of porcine endothelial cells: studies on CD31 and VE-cadherin in adhesion and signaling." Transplantation 68 (6) doi:
Cleary J D, Evans P C, Hikal A H, Chapman S W 1999. "Administration of crushed extended-release pentoxifylline tablets: bioavailability and adverse effects." American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 56 (15) doi:
Maloney S, Smith A, Furst D E, Myerson D, Rupert K, et al. 1999. "Microchimerism of maternal origin persists into adult life." The Journal of clinical investigation 104 (1) doi:10.1172/JCI6611
Evans P C, Lambert N, Maloney S, Furst D E, Moore J M, Nelson J L 1999. "Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma." Blood 93 (6) doi:

1998

Evans P C, Soin A, Wreghitt T G, Alexander G J 1998. "Qualitative and semiquantitative polymerase chain reaction testing for cytomegalovirus DNA in serum allows prediction of CMV related disease in liver transplant recipients." Journal of clinical pathology 51 (12) doi:
Evans P C, Gray J, Wreghitt T G, Alexander G J 1998. "Optimisation of the polymerase chain reaction and dot-blot hybridisation for detecting cytomegalovirus DNA in urine: comparison with detection of early antigen fluorescent foci and culture." Journal of virological methods 73 (1) doi:
Bauer M K, Harding J E, Bassett N S, Breier B H, Oliver M H, et al. 1998. "Fetal growth and placental function." Molecular and cellular endocrinology 140 (1-2) doi:
Nelson J L, Furst D E, Maloney S, Gooley T, Evans P C, et al. 1998. "Microchimerism and HLA-compatible relationships of pregnancy in scleroderma." Lancet 351 (9102) doi:10.1016/S0140-6736(97)08357-8

1997

Harding J E, Evans P C, Gluckman P D 1997. "Maternal growth hormone treatment increases placental diffusion capacity but not fetal or placental growth in sheep." Endocrinology 138 (12) doi:

1995

Oliver M H, Harding J E, Breier B H, Evans P C, Gallaher B W, Gluckman P D 1995. "The effects of ovine placental lactogen infusion on metabolites, insulin-like growth factors and binding proteins in the fetal sheep." The Journal of endocrinology 144 (2) doi:

1994

Liu L, Harding J E, Evans P C, Gluckman P D 1994. "Maternal insulin-like growth factor-I infusion alters feto-placental carbohydrate and protein metabolism in pregnant sheep." Endocrinology 135 (3) doi:
Harding J E, Liu L, Evans P C, Gluckman P D 1994. "Insulin-like growth factor 1 alters feto-placental protein and carbohydrate metabolism in fetal sheep." Endocrinology 134 (3) doi:

1993

Oliver M H, Harding J E, Breier B H, Evans P C, Gluckman P D 1993. "Glucose but not a mixed amino acid infusion regulates plasma insulin-like growth factor-I concentrations in fetal sheep." Pediatric research 34 (1) doi:10.1203/00006450-199307000-00015
Evans P C, Liu L, Harding J E 1993. "Solid-phase separation of 14C-labelled urea and aminoisobutyric acid for membrane transport studies." Journal of chromatography 614 (1) doi:
Evans P C, Ffolliott-Powell F M, Harding J E 1993. "A colorimetric assay for amino nitrogen in small volumes of blood: reaction with beta-naphthoquinone sulfonate." Analytical biochemistry 208 (2) doi:

1992

Oliver M H, Harding J E, Breier B H, Evans P C, Gluckman P D 1992. "The nutritional regulation of circulating placental lactogen in fetal sheep." Pediatric research 31 (5) doi:10.1203/00006450-199205000-00023
Harding J E, Charlton V E, Evans P C 1992. "Effects of beta-hydroxybutyrate infusion on hind limb metabolism in fetal sheep." American journal of obstetrics and gynecology 166 (2) doi:

1991

Harding J E, Evans P C 1991. "beta-Hydroxybutyrate is an alternative substrate for the fetal sheep brain." Journal of developmental physiology 16 (5) doi:

1990

Young D, Evans P C, Paxton J W 1990. "Quantitation of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in plasma by high-performance liquid chromatography." Journal of chromatography 528 (2) doi:
Kestell P, Paxton J W, Evans P C, Young D, Jurlina J L, et al. 1990. "Disposition of amsacrine and its analogue 9-([2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921) in plasma, liver, and Lewis lung tumors in mice." Cancer research 50 (3) doi:

1989

Paxton J W, Evans P C, Hardy J R 1989. "The effect of cimetidine, phenobarbitone and buthionine sulphoximine on the disposition of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulphonylamino)phenylamino]- 4-acridinecarboxamide (CI-921) in the rabbit." Cancer chemotherapy and pharmacology 23 (5) doi:

1988

Paxton J W, Hardy J R, Evans P C, Harvey V J, Baguley B C 1988. "The clinical pharmacokinetics of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulfonylamino)phenylamino]-4 -acridinecarboxamide (CI-921) in a phase 1 trial." Cancer chemotherapy and pharmacology 22 (3) doi:
Kestell P, Paxton J W, Robertson I G, Evans P C, Dormer R A, Baguley B C 1988. "Thiolytic cleavage and binding of the antitumour agent CI-921 in blood." Drug metabolism and drug interactions 6 (3-4) doi:

1987

Paxton J W, Evans P C, Singh R M 1987. "Dose-dependent pharmacokinetics of N-5-dimethyl-9-[(2-methoxy-4-methylsulphonylamino)phenylamino]- 4-acridinecarboxamide (CI-921) in rabbits." Cancer chemotherapy and pharmacology 20 (1) doi:

1975

Evans P C, Reisinger K S 1975. "Rubella susceptibility in Navajo women." The Journal of reproductive medicine 14 (2) doi: